"Airborne, surface, and sub-surface control
Airx Health will save the lives of millions through better management of chronic lung disease, set to become the #1 cause of hospitalization in the US in the coming years. They have created a clinically validated digital solution that can drop hospitalizations by 50%. The founder is equally as impressive with a Stanford trained MD/MBA, experience developing 2 FDA-approved therapies and significant involvement in 2 IPOs. Outside of Soma, Airx is backed by Floodgate, Village Global, ACME (previously Sherpa), and a number of prominent healthcare angels."